Pietro Santulli

ORCID: 0009-0007-6359-0270 · 108 papers in corpus
review 2016

Endometriosis is a benign gynecologic disease, affecting women of reproductive age associated with chronic pelvic pain, dysmenorrhea, dyspareunia and infertility. Ovarian endometrioma (OMA), superficial peritoneal endometriosis (SPE), and d…

other 2016
Fertility and sterility ·doi:10.1016/j.fertnstert.2016.04.014

OBJECTIVE: To study possible associations among endometriosis, pelvic infectious disease, and ART. DESIGN: Retrospective cohort analysis over 4 consecutive years, based on medical records and insurance coding in a tertiary endometriosis re…

lab-animal 2016
Expert opinion on therapeutic targets ·doi:10.1080/14728222.2016.1180367

OBJECTIVE: Mitogen-activated protein kinases (MAPKs) are involved in the proliferation and survival of endometriotic lesions. Vemurafenib (PLX4032) is a novel protein kinase inhibitor that targets BRAF, a member of the MAPK pathway. The pre…

observational 2016
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719116669054

We investigated whether serum osteopontin (OPN) levels are different according to specific phenotypes of adenomyosis and endometriosis. We conducted a prospective laboratory study in a university referral center for endometriosis between Ma…

lab-animal 2015
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719115589410

We investigated whether the myometrium might be intrinsically different in women with adenomyosis. We studied whether the mitogen-activated protein kinases/extracellular signal-regulated kinases (MAPKs/ERKs) and phosphoinositide 3-kinase/ma…

observational 2015
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2014.10.013

STUDY OBJECTIVE: To determine whether cancer antigen-125 (CA-125) levels are increased in women with endometriosis, especially in those with endometriomas (OMAs), deep infiltrating lesions (DIE), and superficial endometriosis (SUP) compared…

lab-animal 2015
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719115592708

INTRODUCTION: Sorafenib is a strong multikinase inhibitor targeting 2 different pathways of endometriosis pathogenesis: RAF kinase and vascular endothelial growth factor receptor (VEGFR). We investigate whether Sorafenib could control the g…

observational 2015
PloS one ·doi:10.1371/journal.pone.0117387

The influence of intrauterine environment on the risk of endometriosis is still controversial. Whether birth weight modifies the risk of endometriosis in adulthood remains an open question. For this purpose, we designed a case-control study…

review 2015
Expert opinion on therapeutic targets ·doi:10.1517/14728222.2015.1090974

INTRODUCTION: The pathogenesis of endometriosis, a common benign disease, remains ill-defined, although it is clear that chronic inflammation plays a crucial role through mitogen-activated protein kinase (MAPK) signaling pathways. All curre…

review 2015
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719115592713

Endometriosis is a benign gynecologic disease, affecting women of reproductive age associated with chronic pelvic pain, dysmenorrhea, dyspareunia and infertility. Ovarian endometrioma (OMA), superficial peritoneal endometriosis (SPE), and d…

observational 2015
PloS one ·doi:10.1371/journal.pone.0119961

BACKGROUND: Endometriosis is a benign gynaecological disease. Abundant bulk of evidence suggests that patients with endometriosis have an immunity dysfunction that enables ectopic endometrial cells to implant and proliferate. Previous studi…

observational 2014
BioMed research international ·doi:10.1155/2014/618964

OBJECTIVES: The identification of epidemiological factors increasing the risk of endometriosis could shorten the time to diagnosis. Specific blood groups may be more common in patients with endometriosis. STUDY DESIGN: We designed a cross-…

review 2014
Expert opinion on pharmacotherapy ·doi:10.1517/14656566.2014.953055

INTRODUCTION: Adenomyosis, characterized by the infiltration of the myometrium by ectopic endometrial islets, is a common condition that causes dysmenorrhea, abnormal uterine bleeding and infertility. Different treatment options exist, incl…

observational 2014
Obstetrics and gynecology ·doi:10.1097/aog.0000000000000464

OBJECTIVE: To assess whether a history of surgery for endometriosis could be considered as a marker for disease severity. METHODS: This cross-sectional study included 780 women with histologically proven endometriosis who underwent surgery…

other 2014
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2014.01.022

OBJECTIVE: The pathogenesis of endometriosis is associated with an inflammatory process. Here, we assessed if the levels of high-sensitivity C-reactive protein (hs-CRP) in serum could constitute an effective method for detecting systemic in…

observational 2014
Human Reproduction ·doi:10.1093/humrep/deu290

STUDY QUESTION: Are protein oxidative stress markers [thiols, advanced oxidation protein products (AOPP), protein carbonyls and nitrates/nitrites] in perioperative peritoneal fluid higher in women with histologically proven endometriosis wh…

review 2013
Expert opinion on pharmacotherapy ·doi:10.1517/14656566.2013.767334

INTRODUCTION: Endometriosis is a common disease that causes pain symptoms and/or infertility in women in their reproductive years. The disease is characterised by the presence of endometrium-like tissue - glands and stroma - outside the ute…

other 2013
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2013-2950

CONTEXT: Endometriosis is a common gynecologic condition characterized by an important inflammatory process mediated by the prostaglandin pathway. Oral contraceptives are the treatment of choice for symptomatic endometriotic women. However …

observational 2013
PloS one ·doi:10.1371/journal.pone.0072069

BACKGROUND: Uterine leiomyomas (fibroids) are the most common gynaecological benign tumors in premenopausal women. Evidences support the role of oxidative stress in the development of uterine leiomyoma. We have analysed oxidative stress mar…

observational 2013
Fertility and sterility ·doi:10.1016/j.fertnstert.2012.08.055

OBJECTIVE: To determine the serum levels of interleukin (IL)-10 family ILs in women with ovarian endometriosis and investigate the correlation of these levels with disease activity. DESIGN: A case-control laboratory study. SETTING: Tertia…

2013
·doi:10.70675/fd1000c0z51a4z4adeza280z2e220e6cd4a0

L’endométriose est une pathologie chronique, bénigne, caractérisée par la présence de tissu endométrial (glande et stroma) en dehors de l’utérus. La forte prévalence de cette maladie, sa symptomatologie invalidante et son coût annuel consid…

observational 2013
Human Reproduction ·doi:10.1093/humrep/det238

STUDY QUESTION: Are interleukin-33 (IL-33) serum levels higher in women with uterine leiomyoma compared with controls without leiomyoma? SUMMARY ANSWER: Serum IL-33 is elevated in women with uterine leiomyoma and correlated with features o…

observational 2012
The American Journal of Pathology ·doi:10.1016/j.ajpath.2012.01.009

Endometrioma is a common ovarian cyst associated with pain and infertility, but its pathogenesis remains enigmatic. Demonstration of the subtelomeric location of hypermethylation in endometrioma has been reported by genome-wide profiling of…

observational 2012
Human Reproduction ·doi:10.1093/humrep/des274

STUDY QUESTION: Are anti-Müllerian hormone (AMH) levels lower in women with endometriosis, notably those with endometriomas (OMAs) and deep infiltrating lesions, compared with controls without endometriosis? SUMMARY ANSWER: Endometriosis a…

review 2012
Expert opinion on emerging drugs ·doi:10.1517/14728214.2012.668885

Introduction: Endometriosis, histologically defined as the presence of endometrium-like tissue - glands and stroma - that develops outside of the uterine cavity, is still an enigmatic disease responsible for pelvic pain and infertility. The…